DAFTAR PUSTAKA
Abbott NJ. Inflammatory mediators and modulation of blood–brain barrier permeability. Cell Molecular Neurobiology; 2000. 20:131–47.
Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood brain barrier. Neurobiology Disease; 2010. 37:13-25.
Agarwal S. Differential Expression of IL-1, TNF-α, IL-6 dan IL-8 in Human Monocytes in Responds to Lipopolysaccharides from Different Microbes. Journal Dental Resets; 1995. 74(4):1057-65.
Alonso M, Collado PS, González-Gallego. Melatonin and its Metabolites as Copper Chelating Agents and their Role in Inhibiting Oxidative Stress. Journal Pineal Resets; 2006. 41:8-14
Amaral JF, Caldwell MD, Miller TA. Metabolic Response to Starvation, Stress, and Sepsis in Modern Surgical Care Physiologic Foundations and Clinical Applications 3rd ed. Miller TA, editor. New York: Informa health care; 2006. 1-32.
Amiry, Moghaddam M, et al., An A-Syntrophin-Dependent Pool of AQP4 in Astroglial Endfeet Confers Bidirectional Water Flow Between Blood and Brain. Product National Acadademic Science USA 100; 2003. 2106–11.
Amiry, Moghaddam M, Xue R, Haug FM, et al., Alpha Syntrophin Deletion Removes the Perivascular But Not the Endothelial Pool of Aquaporin-4 At The Blood-Brain Barrier and Delays The Development Brain Edema in an Experimental Model of Acute Hyponatremia. The FASEB Journal Express Article 10.1096.03-0869. Published Online January 20; 2004.
Arendt J. Melatonin and Human Circadian System. In: A. Miles, D.R.S. Philbrick, C. Thompson, Editors. Melatonin: Clinical perspective. Oxford, Oxford University Press; 1988. 44–61.
Arendt J. Melatonin and Mammalian Pineal Gland. Chapman & Hall, London; 1995. 30:234-39.
Arendt J. Tissue Plasminogen Activator Induced Ischemic Brain Injury is reversed by melatonin. Therapie; 1998. 53:479.
Asahi M, Wang X, Mori T, et al., Effects of Matrix Metalloproteinase-9 Gene Knock-Out on The Proteolysis Of Blood–Brain Barrier and White Matter Components After Cerebral Ischemia. J Neuroscience; 2001. 21:7724–32.
Adibhatla RM, Hatcher JF, and Phospholipase. A2, Reactive Oxygen Species And Lipid Peroxidation In Cerebral Ischemia. Free Radical Biology; 2006. 40:376-87.
Ayer RE, Sugawara T, Zhang JH. Effects of Melatonin in Early Brain Injury Following Subarachnoid Hemorrhage. Acta Neurochirgica Supplement; 2008. 102:327-30.
Aoki K, Uchihara T, Tsuchiya K, Nakamura A, Ikeda K, Wakayama Y. Enhanced Expression of Aquaporin-4 In Human Brain With Infarction. Acta Neuropathology, Berlin; 2003. 106(2):121-124.
Baethmann A, Oettinger W, Rothenfusser W, Kempski O, Unterberg A, Geiger R. Brain Edema Factors: Current Statewith Particular Reference To Plasma Constituents’ Andglutamate. Advance Neurology; 1980. 28:171-95.
Baethmann A, Schurer L, Unterberg A, Wahl W, Staub F, Kempski O. Mediator Substances of Brain Edema In Cerebral Ischaemia. Arzneimittelforschung; German; 1991. 41:310-5.
Bai J, Cederbaum A.I, Protective Effect of Melatonin on Ascorbate-fe Lipid Peroxidation of Polyunsaturated Fatty Acids in Rat Liver and Brain Microsomes. Biology Signals Receptor; 2001. 10:189.
Baratawidjaja KG. Sitokin Dan Kemokin Dalam Imunologi; 2002. 109-33. Beni S.M, Kohen R, Reiter R.J, Tan D.X, Shohami E. Melatonin-Induced
Neuroprotection After Closed Head Injury Is Associated With Increased Brain Antioxidants and Attenuated Late-Phase Activation of NF-kB and AP-1. FASEB J; 2004. 18:149-51.
Beyer C.E, Steketee J.D, Saphier D. The Antidepressant Like Effect of The Melatoni Receptor Ligand Luzindole in Mice. Biochemical Pharmacology; 1998. 56:1265.
Bilici D, Akpinar E, Kiziltune A. Melatonin Limits Lung Injury in Bleomycin Treated Mice. Pharmacology Resets; 2002. 46:133.
Blumbergs PC. Pathology dalam Reilly PL, Bullock R, editors. Head Injury. Pathophysiology and Management. 2nd ed. London: Hodder Arnold; 2005. 41–72.
Burkhardt S, Reiter R.J, Tan D.X, Hardeland R, Cabrera J, Karbownik M. Effect of Mt melatonin Receptor Delation on Melatonin Mediated Phase Shift of Circadian Rhythms. International Journal Biochemical Cell Biology; 2001. 33:775.
Brzezinski A. Mechanism of disease: melatonin in humans. Neurology England Journal Medicine; 1997. 336:186–95.
Candelario-Jalil E, Yang Y, Rosenberg GA. Diverse Roles of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Neuroinflammation and Cerebral Ischemia. Neuroscience; 2009. 158:983–94.
Cardinali D.P, Lynch H.J, Wurtman R.J. Binding of Melatonin to Human and Rat Plasma Protein. Endocrinology; 1972. 91:1213-8.
Centers for Disease Control .Traumatic brain injury in the United States. 2002. Available at: http://www.cdc.gov/ncipc /didop/tbi.htm.
Champier J, Claustrat B, Besancon R, Eymin C, Killer C, Jouvet A, Chamba G, Fevre-Montange M. Seasonal Variations in The Nycthemeral Rhythm. Life Science; 1997. 60:2191.
Cherubini A, Ruggiero C, Polidori M.C, Mecocci P. Free Radical Biology Medicine; 2005. 39:841.
Cighetti G, Pietro A, Luigi A, Luana B, and Rita P. Use Of Methyl Malondialdehyde as an Internal Standard For Malondialdehyde Detection : Validation by Isotope-Dilution Gas chromatography Mass Spectrometry. Clinical Chemistry; 2002. 48:2266-2269.
Connolly D.T. Vascular Permeability Factor: A Unique Regulator of Blood Vessel Function. Journal Cell Biochemical; 1991. 47:219–223.
Cooper P.R. Delayed Brain Injury: Secondary Insults: Central Nervous System Trauma Status Report-1985. William Byrd press/NIH; 1985. 217-28.
Criscuolo G.R. The Genesis Of Peritumoral Vasogenic Brain Edema And Tumor Cysts: A Hypothetical Role For Tumor-Derived Vascular Permeability Factor. Yale Journal Biology Medicine; 1993. 66:277– 314.
Curtin J.F, Donovan M, Cotter T.G. Regulation and Measurement of Oxidative Stress in Apoptosis. Journal Immunology Methods; 2002. 265, 49–72.
Cuzzocrea S, Zingarelli B, Gilad E, Hake P, Salzman A.L, Szabó C. Melatonin Reduces Oxidative Stress and Increases gene Expression In The Cerebral Cortex and CERebellum of Aluminum Exposed Rats. J. Pineal Resets; 1997. 23:106.
Cuzzocrea S, Costantino G, Mazzon E, Caputi A.P. Melatonin Acts as a Growth Stimulating Compound in Some Monocot Species. J. Pineal Resets; 1999. 27:9.
Dauchy R.T, Blask D.E, Sauer L.A, Barinard G.C, Krause J.A. Dim Light During Darkness Stimulates Tumor Progression Fatty Acid Uptake And Metabolism. Cancer Letters; 1999. 144:31–6.
Davies DC. Blood Brain Barrier Breakdown in Septic Encephalopathy and Brain Tumours. J Anat; 2002. 200:639–46.
De Vries C, Escobedo JA, Ueno H, et al., The Fms-Like Tyrosine Kinase, A Receptor For Vascular Endothelial Growth Factor. Science; 1992. 255:989–991.
Droge W. Free Radical In The Physiological Contrtol Of Cell Function. Physiol Rev; 2002. 82:47-95.
Dokka S. Interleukin-10 Mediated Inhibition of Free Radical Generation In Macrophages, Am J Physiol Lung Cell Mol Physiol; 2001. 280:1196-202.
Donkin JJ, Vink R. Mechanisms Of Cerebral Edema In Traumatic Brain Injury. Therapeutic Developments. Current Opinion in Neurology; 2010. 23:293-9.
Ebadi M. Regulation of The Synthesis of MLT and Its Significance to Neuroendocrinology. In: Reiter RJ (ed). The Pineal Gland. Raven Press, New York; 1984. 1-38.
El-shenawy S.M, Abdel-Salam O.M, Baiuomy A.R, El-Batran S, Arbid M. Melatonin Prevents Experimental Liver Cirhosis Induced by Thioacetamide. Pharmacology Resets; 2002. 46:235.
Escames G, López L.C, Tapias V, Utrilla P, Reiter R.J, Hitos A.B, León J, Rodríguez M.I, Acuña-Castroviejo D. J. Pineal Resets; 2006. 40:71. Esterbauer H, Schaur R.J, Zollner H. Free Radical Biology Medicine;
1991. 11:81.
Falo MC, Fillmore HL, Reeves TM, Phillips LL. Matrix Metalloproteinase-3 Expression Profile Differentiates Adaptive and Maladaptive Synaptic Plasticity Induced By Traumatic Brain Injury. J Neurosci Resets; 2006. 84:768–81.
Favier A. Le stress oxydant. Intérêt conceptuel et Expérimental Dans La Compréhension Des Mécanismes Des Maladies et Potentiel Thérapeutique. L’actualité chimique (November–December); 2003. 108–15.
Feng Z, Chang Y, Cheng Y, et al., Melatonin Protect Against Pro-Oxidant Enzymes and Reduces Lipid Peroxidation in Distinct MEMBRANes Induced by The Hydroxyl and Ascorbyl Radicals. J. Pineal Resets; 2004. 37:129.
Ferrara N, Gerber HP, Le Couter J. The Biology of VEGF and Its Receptors. Nat Med; 2004. 9:669-676.
Furuse M, Hirase T, Itoh M, et al., Occludin A Novel Integral Membrane Protein Localizing At Tight Junctions. J Cell Biology; 1993. 123:1777–1788.
Furuse M, Fujita K, Hiiragi T, et al., Claudin-1 and -2: Novel Integral Membrane Proteins Localizing at Tight Junctions With No Sequence Similarity To Occludin. J Cell Biology; 1998. 141:1539-50.
Fujimoto M, Takagi Y, Aoki T, et al., Tissue Inhibitor of Metalloproteinases Protect Blood–Brain Barrier Disruption in Focal Cerebral Ischemia. J Cerebral Blood Flow Metabolism; 2008. 28:1674–85.
Gardès-Albert M, Bonnefont-Rousselot D, Abedinzadeh Z, Jore D. Espèces Réactives de l’oxygène. Comment l’oxygène peut-il devenir toxique? L’actualité chimique November–December; 2003. 91–6.
Gasche Y, Fujimura M, Morita-Fujimura Y, et al., Early Appearance of Activated Matrix Metalloproteinase-9 After Focal Cerebral Ischemia In Mice: A Possible Role In Blood Brain Barrier Dysfunction. J Cerebral Blood Flow Metabolism; 1999. 19:1020–8.
Genovese T, Mazzon E, Crisafulli C, et al., Effects of Combination of Melatonin and Dexamethasone on Secondary Injury in an Experimental Mice Model of Spinal Cord Trauma. J Pineal Resets; 2007. 43: 140-153.
Geppetti P, Bertrand C, Ricciardolo FL, Nadel JA. New Aspects on The Role of Kinins Inneurogenic Inflammation. Canadian Journal Physiology Pharmacology; 1995. 73:843–7.
Ghajar J. Traumatic Brain Injury. Lancet; 2000. 356:923–9.
Gidday JM, Gasche YG, Copin JC, et al., Leukocyte-Derived Matrix Metalloproteinase-9 Mediates Blood Brain Barrier Breakdown and is Proinflammatory After Transient Focal Cerebral Ischemia. Am J Physiol Heart Circ Physiol; 2005. 289:558–568.
Gitto E, Reiter R.J, Cordaro S.P. Oxidative and Inflammatory Parameters in Respiratory Distress Syndrome of Preterm Newborns: Beneficial Effects of Melatonin. Amsterdam Journal Perinatology; 2004. 21: 209–216.
Gusev E, and Skvortnova. Hemodynamic Events Associated With Acut Focal Brain Inschemia PENeumbra-Mediated Vascular Ver Academic/Plenum Publisher. New York; 2003. 1-72.
Ghabriel MN, Thomas A, et al., Magnesium Restores Altered Aquaporin-4 Immunoreactivity Following Traumatic Brain Injury to A Preinjury State. Acta Neurochirgica Supplement; 2006. 96:402-6.
Gong C, Qin Z, Betz A.L, Liu X.H, Yang G.Y. Perfusion Of Melatonin Into The Prefrontal Cortex Disprupts The Circadian Rhythm of Acetylcholine. Brain Resets; 1998. 801:1.
Haldar C, Singh R, Guchhait P. Protective Effect of MELATONIN Against Fractionated Irradiation Induced Epiphyseal Injury. Chronobiology International; 2001. 18: 61.
Hall JC. Cycling Transcript and The Circadian Lock. Current Biology; 1991. 1:89-90.
Halliwell B, Gutteridge J.M.C. Free Radicals in Biology and Medicine, third ed. Oxford University Press; 1999. 879-889.
Hardeland R, Pandi-Perumal S.R. Melatonin, a Potent Agent in Antioxidative Defense: Actions as a Natural Food Constituent, Gastrointestinal Factor, Drug and Prodrug. Nutrions Metabolism. London; 2005. 2:22.
Hayakata T, Shiozaki T, Tasaki O, et al., Changes in CSF S100B and Cytokine Concentrations in Early-Phase Severe Traumatic Brain Injury. Shock; 2004. 22:102–107.
Hayes R, Jenkins L.W, Lyeth B.G. Neurotransmitters Mediated Mechanism of Traumatic Brain Injury: Acetylcholineand Excitatory Amino Acids. Central Nervous System Trauma Status Report; 1991. 173-88.
Hirano T, Akira S, Taga T. Biological and Clinical Aspects of Interleukin 6, Immunology Today; 1990. 11:443-9.
Hirase T, Staddon J.M, Saitou M, et al., Occludin as a Possible Determinant of Tight Junction Permeability in Endothelial Cells. J Cell Science; 1997. 110:1603–13.
Holston K. Helicobacter Pylori: An Emerging Pathogen, Departmen of Bacteriology University of Wisconsin-Madison; 1997. 1-6.
Homsi S, Federico F, Croci N, et al., Minocycline Effects on Cerebral Edema: Relations With Inflammatory and Oxidative Stress Markers Following Traumatic Brain Injury in Mice. Brain Research; 2009. 1291:122–132.
Hsu CY, Hu ZY, Doster SK. Cell Mediated Injury in: Narayan RK, Wilberger JE, Povlishock JT. Neurotrauma. McGraw Hill; 1995. 1433-44.
Hu H, Yao Hong-tian, Zhang Wei-ping, et al., Increased Expression of Aquaporin-4 in Human Traumatic Brain Injury and Brain Tumors. J Zhejiang Univ SCI, 6B(I); 2005. 33-7.
Huether G, Poeggeler B, Reimer A, et al., Effect of Tryptophan Administration on Circulating Melatonin Levels in Chicks and Rats: Evidence for Stimulation of Melatonin Synthesis and Release in The Gastrointestinal Tract. Life Science; 1992. 52: 945–53.
Hutchinson PJ, O’Connell MT, Rothwell NJ. Inflammation in Human Brain Injury: Intracerebral Concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1ra. J. Neurotrauma; 1992. 24.1545–1557. Ito H, Yamamoto N, Arima H. Interleukin-1beta Induces the Expression Of
Aquaporin-4 Through A Nuclear Factor-Kappa Pathway in Rat Astrocytes. J. Neurochem; 2006. 99:107–118.
Janigro D, West G.A, Nguyen T.S, Winn H.R. Urinary 6-hydroxy-Melatonin-sulfate Excretion and Ciradian Rhythm in Patients. Circ. Res; 1994. 75:528.
Jain RK. Molecular Regulation Of Vessel Maturatio. Nat Med; 2003. 9:685-693.
Jung M, Drapier J.C, Weidenbach H, Renia L, Oliveira L, Wang A, Beger, H.G, Nussler A.K. Mitochondria Catastrophe During Doxorubicin Induced Cardiotoxicity. J. Hepatol; 2000. 33:387.
Kaal Evert C.A, Charles, J.Vecht. The Management of Brain Edema in Brain Tumors, Cure Opinion Oncology; 2004. 16:593-600
Kakulavarapu V, Rao R, Reddy PV. Aquaporin-4 Expression in Cultured Astrocytes After Fluid Percussion Injury. Journal of Neurotrauma; 2011. 28:371-81.
Kaur C, Sivakumar V, Zhang Y, Ling EA. Hypoxia-Induced Astrocytic Reaction and Increased Vascular Permeability in The Rat Cerebellum. Glia; 2006. 54:826.
Kaur C, Sivakumar V, Yong Z. Protective Effect of MELatonin of Cigarette Smoke Induced. J. Pathol; 2007. 212, 429.
Kaur C, Sivakumar V, Ling EA. Melatonin and Its Therapeutic Potential in Neuroprotection. Central Nervous System Agents in Medicinal Chemistry; 2008. 260-6.
Kerman M, Cirak B, Ozguner MF, et al., Does Melatonin Protect or Treat Brain Damage From Traumatic Oxidative Stress? Exp Brain Res; 2005. 163: 406-410.
Ke Ding. Melatonin’s Protection Against Human Prion-Mediated neurotoxicity. Neurochemistry International; 2014. 76:23-31.
Klatzo I. Presidental Address. Neuropathological Aspects of Brain Edema. J Neuropathol Exp Neuro; 1967. 26:1–14
Kleffner I, Bungeroth M, Schiffbauer H, et al., The Role of Aquaporin-4 Polymorphisms in the Development of Brain Edema After Middle Cerebral Artery Occlusion. Stroke; 2008. 39:1333-5.
Kondoh T, Uneyama H, Nishino H, Torii K. Life Science; 2002. 72, 583. Kossman MCM. Inflammatory Responses to Traumatic Brain Injury: an
Overview for the New Millenium dalam: Rothwell N, Loddick S; Immune and Inflammatory Responses in the Nervous System, Oxford university press: 106-26.
Lazovic J, Basu A, Lin H.W. Neuroinflammation and Both Cytotoxic and Vasogenic Edema are Reduced in Interleukin-1 type 1 Receptor Deficient Mice Conferring Neuroprotection. Stroke 36; 2005. 2226– 2231.
Lezlinger P,M, Morganti-Kossmann M.C, Laurer H.L, et al., The Duality of The Inflammatory Response to Traumatic Brain Injury. Molecular Neurobiology; 2001. 24:169–181.
Lezlinger Satman, Raghupati R. Overview of Basic Mechanisms Underlying Neuropathological Consequences of Head Trauma, Miller LP, Hayes RL. Head Trauma Basic, Preclinical, and Clinical Directions New York. Wiley-Liss; 2001. 3-36.
Li J.H, Yu J.P, Yu H.G. Melatonin Reduces Inflammatory Injury Through Inhibiting NF-kappaB Activation In Rats With Colitis. Mediators Inflammation; 2005. 185–193.
Liang Z.Q, Li Y.L, Zhao X.L, Han R, Wang X.X, Wang Y, Chase T.N, Bennett M.C, Qin Z.H. Mitochondria Catasrophe During Doxorubicin Induced. Brain Res; 2007. 1145:190.
Liebner S, Fischmann A, Rascher G, et al., Claudin-1 and Claudin-5 Expression and Tight Junction Morphology are Altered in Blood Vessels of Human Glioblastoma Multiforme. Acta Neuropathol (Berl); 2000. 100:323–331.
Lin E, Lowry SF, Calvano SE. Mediators of Inflammation and Injury dalam Surgery: Scientific Basis and Evidence-Based Practice. Norton JA, Bollinger RR, Chang AE, editor. New York: Springer-Verlag; 2001. 69-94.
Lipton P. Ischemic Call Death In Brain Neurons. Physiological Review; 1999. 79:1431-1516.
Liu C, Fukuhara C, Wessel J.H., et al., Liposomal Melatonin Rescues Methamphetamine E-elicited Mitochondrial. Cell Tissue Res; 2004. 315:197.
Lotufo C.M, Lopes C, Dubocovich M.L, et al., Modulates Natural Leaf Senescence Through Melatonin Medicated Pathway. Europe Journal Pharmacology; 2001. 430:351.
Maas AIR, Dearden M,C, et al., Current Recommendation for Neuro Trauma, Current Opinion in Critical Care; 2000. 6:281-92.
Maestroni G.J. Expert Opinion Investigation Drugs; 2001. 10:467.
Manley GT, Fujimura M, Ma T, et al., Aquaporin-4 Deletion in Mice Reduces Brain Edema After Acute Water Intoxication and Ischemic Stroke. National medicine; 2000. 6:159-63.
Marmarou A, Fatouros P, Barzo P, et al., Contribution of Edema and Cerebral Blood Volume to Traumatic Brain Swelling in Head Injured Patients. Journal Neurosurgical; 2000. 93:183-93.
Marmarou A, Fatouros P, Signoretti S, et al., Predominance of Cellular Edema In Traumatic Brain Swelling in Patients With Severe Head Injuries. J Neurosurgical; 2006. 104:720-30.
Mallo C, Zaidan R, Galy G, et al., Pharmakokinetics of MLT in Man After Intravenous Infusion and Bolus Injection. Europe Journal Clinic Pharmacology; 1990. 38:297-301.
Martin–Padura I, Lostaglio S, Schneemann M, et al., Junctional Adhesion Molecule, a Novel Member of The Immunoglobulin Superfamily That Distributes At Intercellular Junctions and Modulates Monocyte Transmigration. Journal Cell Biology; 1998. 142:117–27.
Mayhan WG. VEGF Increases Permeability of the blood–brain Barrier Via A Nitric Oxide Synthase/Cgmp-Dependent Pathway. Amstherdam journal physiology; 1999. 276:C1148–C1153.
Mayo J.C, Sainz R.M, Tan D.X, Antolín I, Rodríguez C, Reiter R.J. Exogenous Melatonin Supplementation. Endocrine; 2005. 27:169. McKeating EG, Andrew PJ. Cytokines and Adhesion Molecule in Acute
Brain Injury; British Journal of Anaesthesia; 1998. 80:77-84.
McIntosh TK, Juhler M, Raghupati R. Secondary Brain Injury: Neurochemical and Cellular Mediators dalam: Marion DW : Traumatic Brain Injury. New York. Stuttgart Thieme; 1999. 39-55. Mei Bin Z, Susan G, Elner, Victor M. Elner. Regulation of VEGF mRNA
Meki A.R, Hussein A.A. Component Biochemical Physiology Care. Toxicology. Pharmacology; 2001. 130:305.
Meng S, Qiao M, Lin L, Del Bigio MR, Tomanek B, Tuor UI. Correspondence of AQP4 Expression and Hypoxic–Ischaemic Brain Oedema Monitored by Magnetic Resonance Imaging in The Immature and Juvenile Rat. Europe Journal Neuroscience; 2004. 19: 2261–9.
Mesenge C, Morgaill I, Verrecchia C, Allix M, Boulu RG, Plotkine M. Protective Effect of Melatonin in a Model of Traumatic Brain Injury in Mice. J Pineal Res; 1998. 25:41-46.
Millauer B, Wizigmann–Voos S, Schnurch H, et al., High affinity VEGF Binding and Developmental Expression Suggest Flk-1 as a Major Regulator of Vasculogenesis and Angiogenesis; 1993. Cell: 72:835– 846.
Mistraletti G, Sabbatini G, Taverna, et al., Pharmackinetics of Orally Administered Melatonin in Critically Ill Patients. J. Pineal Res; 2010. 20:15.
Morera AL, Abreu-Gonzalez P, Henry M. Melatonin as a Biological Marker in Schizophrenia. Springer Science; 2009. 107-17.
Morganti-Kossman MC, Rancan M. Inflammatory Response in Acute Traumatic Brain Injury: a Double-Edge Sword. Current opinion in Critical Care; 2002. 8:101-5.
Murray DJ, Thomas AW. Protective and Patogenic Functions of Macrophage Subset, J. Nature, Rev. Immunol, Nov: (11); 2011. 723-37
Nag S, Manias JL, Stewart DJ. Pathology and New Players in The Pathogenesis of Brain Edema. Acta Neuropathology; 2009. 118:197– 217.
National Head Injury Foundation. Clasification Of Head Injury; 1985.
Nordlund J.J, Lerner A.B. The Effects of Oral Melatonin on Skin Color and on The Release of Pituitary Hormones. J. Clinical Endocrinology Metabolism; 1977. 45:768–74.
Nowak J.Z, Zawilska J.B. Prevents Oxidative Stress-evoked DNA Damage. Pharmacology World Science; 1998. 20:18.
Owuor E.D, Kong A.N. Antioxidants and Oxidants Regulated Signal Transduction Pathways. Biochemical Pharmacology; 2002. 64:765– 770.
Ozturk G, Cokun S, Erba D, Hasanoglu E. Melatonin Attenuates Hypoxic Pulmonary. Japan Journal Physiology; 2000. 50:149.
Perhimpunan Dokter Spesialis Patologi Indonesia (IAPI). Pedoman Penanganan Bahan Pemeriksaan untuk Histopatologi, Jakarta; 2008. Pallab B, Anand KP, Sudip P, Ranjana P. The Imflammation and The Proferation of Pulmonary Arterial Smooth Muscle. Life Sciences; 2014. 199:97-109.
Pablos M.I, Agapito M.T, Gutierrez R. J. Pineal Res; 1995. 19:111.
Papadopoulos MC, Saadoun S, Davies DC, et al., Emerging Molecular Mechanisms of Brain Tumour Oedema. British Journal Neurosurgery; 2001. 15:101–108.
Papadopoulos MC, Saadoun S, Woodrow CJ, et al., Occludin Expression in Microvessels of Neoplastic and Non-neoplastic Human Brain. Neuropathology Application Neurobiology; 2001. 27: 384–95.
Papadopoulos MC, Manley GT, Krishna S, Verkman AS. Aquaporin-4 Facilitates Reabsorption of Excess Fluid in Vasogenic Brain Edema. FASEB J; 2004. 18:1291-3.
Papadopoulos MC, Verkman AS. Aquaporin-4 Gene Disruption in Mice Reduces Brain Swelling and Mortality in Pneumococcal Meningitis. J Biology Chemical; 2005. 280:13906–12
Papadopoulos MC, Verkman AS. Aquaporin-4 and Brain Edema. Pediatric Nephrology; 2007. 22:778-84.
Pei Z, Cheung R.T. Melatonin and Its metabolites as Copper and Chelating Agents. J. Pineal Res; 2004. 37:85.
Plesnila N, Schulz J, Stoffel M, et al., Role of Bradykinin B2 Receptors in the Formation of Vasogenic Brain Edema in Rats. J Neurotrauma; 2001. 18:1049–58.
Pizzi M, Spano P. A Physicochemical Analysis and Their Role in Inhibiting Oxidative Stress. Europe Journal Pharmacology; 2006. 545:22. Prat A, Biernacki K, Wosik K, Antel J.P. Melatonin Compensates Silencing
of Heat Shock Protein. Glia; 2001. 36:145.
Puri SK, Patna Bihar. Cerebral Edema and its Management, MJAFI (59); 2003. 326-331.
Rahman A, Kefer J, Bando M, et al., E-Selectin Expression in Human Endothelial Cells by TAlpha-Induced Oxidant Generation and NF-kappaB Activation; 1998. 275:533-44.
Rash JE, Yasumura T, Hudson CS, et al., Direct Immunogold Labeling of Aquaporin-4 in Square Arrays of Astrocyte and Ependymocyte Plasma Membranes in Rat Brain and Spinal Cord. Proc Natl Acad Sci USA; 1998. 95:11981–11986.
Reiter RJ. Pineal Melatonin: Cell Biology of Its Synthesis and of Its Physiological Interactions. Endocrine Rev; 1991. 12:151-80.
Reiter R.J, Guerrero J.M, Escames G, et al., Ann. N. Y. Academica Science; 1997. 825:70.
Reiter R.J, Tan D.X, Manchester L.C, et al., Suppresses UVR-Induced Inflammation in Human Skin ex Vivo and Cultured Keratinocytes. Advance Expriment Medicine Biology; 2003. 527:539.
Reiter R.J, Tan D.X, Gitto E, et al., Pharmacological Utility of Melatonin in Reducing Oxidative Cellular and Molecular Damage. Pol. J. Pharmacology; 2004. 56:159–170.
Reiter R.J, Tan D.X, Leon J, Kilic U, Kilic E. Melatonin Feedback on Clock Genes. Experiment Biology Mediocine, Maywood; 2005. 230:104. Reulen HJ, Huber P, Ito U, et al., Peritumoral Brain Edema. A Keynote
RibeiroMde C, Hirt L, Bogousslavsky J, et al., Time Course of Aquaporin Expression After Transient Focal Cerebral Ischemia in Mice. J Neurosci Res; 2006. 83:1231–1240.
Rite I, Alberto M, Josefina C, Jose LV. Intracerebral VEGF Injection Highly Upregulates AQP-4 mRNA and Protein in Perivasculer Space and Glia Limitans Externa. Neurochemestry International, Vol 52, Issues 4-5, March-April; 2008. 897-903.
Romieu I, Albino, Barraza-Villareal, and Anna-Carin Olin. Exhaled Breath Malondialdehyde as a Marker of Effect of Exposure to Air Pollution in Children With Asthma. American Accademy of Allergy. Asthma and Immunology Journal; 2008. 903-909.
Rosner MJ, Rosner MD. Cerebral Prefusion Pressure: Management Protocol and Clinical Results. Journal Neurosurgical; 1995. 83: 949-62.
Rosenberg GA, Yang Y. Vasogenic Edema Due to Tight Junction Disruption by Matrix Metalloproteinases in Cerebral Ischemia. Neurosurgery Focus; 2007. 22: 4.
Rosenberg GA. Matrix Metalloproteinases and their Multiple Roles in Neurodegenerative Diseases. Lancet Neurology; 2009. 8:205–16. Saadoun S, Papadopoulos MC, Davies DC, et al., Aquaporin-4 Expression
is Increased in Oedematous Human Brain Tumours. Journal Neurology Neurosurgery Psychiatry; 2002. 72:262–5.
Saleh A, Wiedermann D, Schroeter M, et al., Melatonin Prevents Cell Death and Mitochondrial Dysfunction. NMR Biomed; 2004. 7.63. Samanta S, Sribnick EA, Das A, et al., Melatonin Attenuates Calpain
Upregulation, Axonal Damage, and Neuronal Death in Spinal Cord Injury. Journal Pineal Resets, In Press; 2008.
Sandoval KE, Witt KA. Blood Brain Barrier Tight Junction Permeability and Ischemic Stroke. Neurobiology Disease; 2008. 32:200-219.
Sarrafzadeh AS, Thomale VW, Kroppenstedt SN, et al., Neuroprotective Effect of Melatonin on Cortical Impact Injury in the rat. Acta Neurochirgica; 2002.142: 1293-1299.
Shukla A, Dikshit M, Srimal R.C. Dependent Mechanism DURIng Ischemic Stroke In Mice. Experentia; 1996. 52:136.
Sivakumar V, Lu J, Ling E.A, Kaur C. Tissue Plasminogen Activator Induced Ischemic Brain Injury. Brain Pathology; 2008. 18:71.
Srinivasan V, Smits M, Spence W, et al., Melatonin Selenium Nanoparticles Inhibits Oxidative Stress. World J. Biology Psychiatry; 2006. 7:138.
Srinivasan V, Spence D.W, Moscovitch A. Malaria: Therapeutic Implications of Melatonin. J.Pineal Reset; 2010. 48:1–8.
Subramanian P, Mirunalini S, Pandi-Perumal S.R. Expression of MT2 not MT1 Melatonin Receptors. Europe Journal Pharmacology; 2007. 571:116.
Sugden D. Melatonin Biosynthesis in The Mammalian Pineal Gland. Experientia; 1989. 45:922-32.
Sumber Departemen Patologi Anatomi Fak. Kedokteran USU
Sun MC, Honey CR, Berk C, et al., Regulation of Aquaporin-4 in Traumatic Brain Injury Model in Rats. J Neurosurgica; 2003. 98:565-9.
Supardi. Aplikasi Statistika dalam Penelitian. UFUK EDU, Jakarta; 2012. Tan D.X, Manchester L.C, Reiter R.J, Qi W, Hanes M.A, Farley N.J. High
Physiological Levels of Melatonin in Bile of Mammals. Life Science; 1999. 65:2523–9.
Taniguchi M, Yamashita T, Kumura E, et al., Induction of Aquaporin-4 Water Channel mRNA After Focal Cerebral Ischemia in rat. Brain Resets Molecular; 2000. 78(1-2):131-7.
Taya K, Gulsen S, Okuno K, et al., Modulation of AQP4 Expression by The Selective V1a Receptor Antagonists, SR49059, Decrease Trauma-Induced Brain Edema. Acta Neurochirgica Supply; 2008. 102:425-9. Taya K, Marmarou C, Okuno K. Effect of Secondary Insults Upon
Aquaporin-4 Water Channels Following Experimental Cortical Contusion in Rats. J Neurotrauma; 2009. 27:229–239.
Tejima E, Guo S, Murata Y, et al., Neuroprotective Effects of Over-Expressing Tissue Inhibitor of Metalloproteinase TIMP-1. J Neurotrauma; 2009. 26:1935–1941.
Thiel V.E, Audus K.L. Lipogenesis in Adipose Tissue From Pinealectomized Rats Adapted. Antioxidation Redox Signal; 2001. 3, 273.
Torii K, Uneyama H, Nishino H, Kondoh T. Melatonin Suppresses Cerebral Edema Caused By Middle Cerebral Artery Occlusion/ Reperfusion In Rats Assessed By Magnetic Resonance Imaging. J. Pineal Resest; 2004. 36:18-24.
Tosini G, Menaker M. Inhibits Oxidative Stress and Protect Against Lipopolysaccharide in Mice. Brain Resets; 1998. 789:221.
Tourdias T, Dragonu I, Fushimi Y, et al., Aquaporin 4 Correlates With Apparent Diffusion Coefficient And Hydrocephalus Severity in The Rat Brain: A Combined Mri-Histological Study. Neuroimage; 2009. 47:659-66.
Tourdias T, Mori N, Dragonu I, et al., Differential Aquaporin 4 Expression During Edema Build-Up And Resolution Phases of Brain Inflammation. Journal of Neuroinflammation; 2011. 8:143:1-16. Trabold R, Eros C, Zweckberger K, et al., The Role Of Bradykinin B(1)
And B(2) Receptors For Secondary Brain Damage After Traumatic Brain Injury in Mice. J Cerebral Blood Flow Metabolism; 2010. 30:130–139.
Tütüncüler F, Eskiocak S, Baran UN, Ekuklu G, Ayvaz S, Vatansever U. Pediatric International; 2005. 47:434.
Unterberg AW, Stover J, Kress B, et al., Edema and Brain Trauma. Neuroscience; 2004. 129:1021-9.
Vajda Z, Pedersen M, Fuchtbauer EM, et al., Delayed Onset of Brain Edema and Mislocalization of Aquaporin-4 in Dystrophin-Null Transgenic Mice. Proc Natl Acad Sci USA 99; 2002. 13131–13136. Verkman AS. Physiological Importance of Aquaporin Water Channels.
Annual Medicine; 2002. 34:192-20.
Vilalta A, Sahuquillo J, Rosell A, et al., Moderate and Severe Traumatic Brain Injury Induce Early Overexpression of Systemic and Brain Gelatinases. Intensive Care Medicine; 2008. 34:1384–92.
Villeges G, Baerbel LS, Alda Tufro. Autocrine and Paracrine Functions of Vascular Endothelial Growth Factor (VEGF) In Renal Tubuler Epithelial Cell. J. Kidney International; 2005. 67:449-457.
Viljoen M, Steyrn ME, Von Rensburg BW, et al., Melatonin in Chronic Renal Failure. Nephrology; 1992. 60:138-42.
Visser J, Labadarios D. Metabolic and Nutritional Consequences of The Acute Phase Response. SAJCN15; 2002. (3):75-94.
Von Bockstaele BB. Melatonin: The Proven Wonder Drug. www.digitaljournal.com; 2007.
Wagner KR. The Antidepresant-Like Effect of The Melatonin Receptor Ligand Luzindole In Mice. Stroke, (Supplement.38); 2007. 753.
Wang X, Jung J, Asahi M, et al., Effects of Matrix Metalloproteinase-9 Gene Knock-Out on Morphological and Motor Outcomes After Traumatic Brain Injury. J Neuroscience; 2000. 20:7037–7042.
Walter MF, Jacob Rf, Jeffers B, Ghadanfar MM, Preston GM, Buch J, and Mason RR. Serum Level Of Thiobarbitusic Acid Reactive Substances Predict Cardiovascular Events In Patients With Stable Coronary Artery Disease: ALongitudinal Analysis Of The Prevent Study. J.Am. Coll. Cardiol; 2004. 44:1996-2002.
Weigand MA, Laipple A, Plaschle K, Eckstein HH, Martin E, and Bardenheuer HJ. Concertration Changes Of Malondialdehyde Acros The Cerebral Vascular Bed And Shedding Of L-Selection During Carotid Endarterectomy. Stroke; 1999. 30:306-11.
Weishaupt J.H, Bartels C, Pölking E, Dietrich J, Rohde G, Poeggeler B, Mertens N, Sperling S, Bohn M, Hüther G, Schneider A, Bach A, Sirén A.L, Hardeland R, Bähr M, Nave K.A, Ehrenreich H. Protective of Melatonin Against Fractionated Irradiation. J. Pineal Resets; 2006. 41:313.
Winter CD, Pringle AK. Raised Parenchymal Interleukin-6 Levels Correlate With Improved Outcome After Traumatic Brain Injury. Brain 172 (2); 2004. 315-20.
Yu J.H, Lim J.W, Namkung W, Kim H, Kim K.H. Gene Expression in The Cerebral Cortex Of Aluminum-Exposed. Lab. Invest; 2002. 82,1359. Yun H.Y, Dawson V.L, Dawson T.M. Neurobiology Of Nitric Oxide. Crit.
Rev. Neurobiol; 1996. 10, 291–316.
Zador Z, Bloch O, Yao X, Manley GT. Aquaporins: Role in Cerebral Edema and Brain Water Balance. Prog Brain Res; 2007. 161:185– 94.
Zausinger S, Lumenta DB, Pruneau D, et al., Therapeutical Efficacy of a Novel Nonpeptide Bradykinin B2 Receptor Antagonist on Brain Edema Formation and Ischemic Tissue Damage in Focal Cerebral Ischemia. Acta Neurochirgica Supply; 2003. 86:205–7.
Zhang Z.G, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, Bruggen N, Chopp M. J. Clin. Invest; 2000. 106:829.
Zhang Z.G, Zhang L, Tsang W, Soltanian-Zadeh H, Morris D, Zhang R, Goussev A, Powers C, Yeich T, Chopp. M. J. Melatonin of Brain Injury Protective. Induction of Aquaporin-4 Water Channel mRNA. Cereb. Blood Flow Metab; 2002. 22:379.
